Evotec SE (EVO) Operating Margin (2009 - 2025)
Evotec SE (EVO) reported Operating Margin of 14.92% for Q4 2025, up 1239.0% on a YoY basis from 1.11% in Q4 2024, and up 154.96% sequentially from 27.15% in Q3 2025.
Evotec SE (EVO) Operating Margin (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 9 years of Operating Margin data on file, last reported at 14.92% in Q4 2025.
- For the quarter ending Q4 2025, Operating Margin rose 1239.0% year-over-year to 14.92%; the trailing twelve-month figure through Dec 2025 stood at 3.36% (up 44.0% YoY), and the FY2025 full-year result was 0.01%, up 1787.0% from the prior year.
- Operating Margin improved to 14.92% in Q4 2025, from 27.15% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 38.98% in Q1 2021 to a low of 27.15% in Q3 2025.
- A 5-year average of 4.07% and a median of 4.9% in 2021 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin tumbled 4013 bps in 2021 and jumped 1239 bps in 2025, its largest moves.
- Tracing EVO's Operating Margin over 5 years: stood at 6.05% in 2021, then tumbled by 155 bps to 3.3% in 2022, then plunged by 88 bps to 6.2% in 2023, then soared by 141 bps to 2.53% in 2024, then surged by 489 bps to 14.92% in 2025.
- Business Quant data shows EVO's Operating Margin at 14.92% in Q4 2025, 27.15% in Q3 2025, and 2.53% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.92% |
| Sep 30, 2025 | -27.15% |
| Dec 31, 2024 | 2.53% |
| Sep 30, 2024 | -14.33% |
| Dec 31, 2023 | -6.20% |
| Sep 30, 2023 | 6.21% |
| Jun 30, 2023 | -16.99% |
| Dec 31, 2022 | -3.30% |
| Sep 30, 2022 | 7.78% |
| Jun 30, 2022 | -2.19% |
| Mar 31, 2022 | 38.78% |
| Dec 31, 2021 | 6.05% |
| Sep 30, 2021 | 11.11% |
| Jun 30, 2021 | 4.90% |
| Mar 31, 2021 | 38.98% |
| Dec 31, 2020 | 46.18% |
| Dec 31, 2019 | 14.05% |
| Sep 30, 2010 | 4.84% |
| Jun 30, 2010 | 12.01% |
| Mar 31, 2010 | -14.98% |